Internal Medicine • Research • Visualized VISUALIZED: A Phase 2a/b Trial of Triheptanoin for Ataxia-Telangiectasia: Efficacy, Safety, and Novel Biomarker Identification 1 min read Read further: A Phase 2a/b Trial of Triheptanoin for Ataxia-Telangiectasia: Efficacy, Safety, and Novel Biomarker Identification FacebookXPinterestLinkedIn
Article NL C.36(2026) • Internal Medicine Evidence-Based Analysis of Botox and Oral Medications... 3 min read
Article NL C.36(2026) • Internal Medicine Beyond Radiological Reads: Tracking Pre-Symptomatic AD... 3 min read
Article NL C.36(2026) • Internal Medicine Enzymatic Modulation of the Retinal Barrier Enhances... 3 min read
Article NL C.36(2026) • Internal Medicine Genomic-Guided Immunotherapy Achieves Complete... 3 min read